Nurix Therapeutics, Inc.

NRIX

Nurix Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Arthur T. Sands, with a market cap of $1.8B.

Market cap

$1.77B+94.2%

We’re still putting together Nurix Therapeutics, Inc.’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Earnings

Q1 2026 report

April 8, 2026

Revenue$6.3MMiss by $8.0M EPS-$0.79Miss by $0.03

Read the full report

Next report

Jul 9, 2026 (In 2 weeks)

Revenue estimate$15.9M

EPS estimate-$0.73

Profile

CountryUnited States of America

Listed2020

Employees284.0

CEOArthur T. Sands

SectorHealthcare

IndustryBiotechnology

Websitenurixtx.com

FilingsSEC EDGAR